FDA
approval
· 2022-02-03
FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (AvKARE)
Summary
The FDA approved AvKARE's supplemental application for a generic combined oral contraceptive containing norgestimate and ethinyl estradiol.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORGESTIMATE AND ETHINYL ESTRADIOL (NORGESTIMATE AND ETHINYL ESTRADIOL)